Abstract
Few data are available on the kinetic of the airways’ inflammation induced by inhaled endotoxin in a given subject. The purpose of this study was to evaluate in healthy subjects the time-related endotoxin-induced airways’ inflammation. The cells counts from the induced-sputum were evaluated before, 6 and 24 h, and 7 days after an exposure to 20 mcg inhaled endotoxin, in eight pre-selected volunteers. To avoid interference of the induced-sputum procedure on the response to endotoxin, each time-point was evaluated in randomized order at 2-weeks interval after three separate inhalations of endotoxin. A significant rise of the relative number of lymphocytes (p < 0.05) and polymorphonuclear neutrophils (PMN; p < 0.02) and of the absolute number of PMN (p < 0.05) occurring at 6 h, followed by an increase of the absolute number of the total viable cells (p < 0.01), macrophages (p < 0.001), neutrophils (p < 0.01), and lymphocytes (p < 0.05) at 24 h after endotoxin inhalation. The inflammatory response recovered totally after 7 days. In human beings, the inhalation of endotoxin induced a transient airway inflammation after 6 h, peaked at 24 h and recovered after 7 days. When repeated endotoxin inhalations are used as a model of inflammation, a wash-out period of at least 7 days should be applied between each exposure in each subject.
Similar content being viewed by others
REFERENCES
Rylander R, editor (1997) Endotoxins in the environment: a criteria document. Int J Occup Environ Health 3 (suppl 1): S1–S48.
Hasday, J.D., R. Bascom, J.J. Costa, T. Fitzgerald, and W. Dubin. 1999. Bacterial endotoxin is an active component of cigarette smoke. Chest 115: 829–835.
Park, J.-H., D.R. Gold, D.L. Spiegelma, H.A. Burge, and D.K. Milton. 2001. House dust endotoxin and wheeze in the first year of life. American Journal of Respiratory and Critical Care Medicine 163: 322–328.
Thorne, P.S., K. Kulhankova, Yin, R. Cohn, S.J. Arbes, and D.C. Zeldin. 2005. Endotoxin exposure is a risk factor for asthma. American Journal of Respiratory and Critical Care Medicine 172: 1371–1377.
Michel, O., J. Kips, J. Duchateau, F. Vertongen, L. Robert, H. Collet, R. Pauwels, and R. Sergysels. 1996. Severity of asthma is related to endotoxin in house dust. American Journal of Respiratory and Critical Care Medicine 154: 1641–1646.
Schwartz, D.A., K.J. Donham, S.A. Olenchock, W.J. Popendorf, D.S. Van Fossen, L.F. Burmeister, and J.A. Merchant. 1995. Determinants of longitudinal changes in spirometric functions among swine confinement operators and farmers. American Journal of Respiratory and Critical Care Medicine 151: 47–53.
Michel, O., R. Ginnani, B. Le Bon, J. Content, R. Sergysels, and J. Duchateau. 1992. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. American Review of Respiratory Disease 146: 352–357.
Nightingale, J.A., D.F. Rogers, L.A. Hart, S.A. Kharitonov, K.F. Chung, and P.J. Barnes. 1998. Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects. Thorax 53: 563–571.
Michel, O., M. Dentener, F. Corazza, W. Buurman, and R. Rylander. 2001. Normal subjects express differences in clinical responses to inhaled lipopolysaccharide wich are related with inflammation and with atopy. The Journal of Allergy and Clinical Immunology 107: 797–804.
Alexis, N.E., M.W. Eldridge, and D.B. Peden. 2003. Effect of inhaled endotoxin on airway and circulating inflammatory cell phagocytosis and CD11b expression in atopic asthmatic subjects. The Journal of Allergy and Clinical Immunology 112: 353–361.
Kitz, R., M.A. Rose, K. Placzek, J. Schulze, S. Zielen, and R. Schubert. 2008. LPS inhalation challenge: a new tool to characterize the infammatory response in humans. Medical Microbiology and Immunology 197: 13–19.
Groneberg, D.A., and K.F. Chung. 2004. Models of chronic obstructive pulmonary disease. Respiratory Research 5: 18–34.
O’Grady, N.P., H.L. Preas, J. Pugin, C. Fiuza, M. Tropea, D. Reda, S.M. Banks, and A.F. Suffredini. 2001. Local inflammatory responses following bronchial endotoxin instillation in humans. American Journal of Respiratory and Critical Care Medicine 163: 1591–1598.
Loh, L.C., B. Vyas, V. Kanabar, D.M. Kemeny, and B.J. O’Connor. 2006. Inhaled endotoxin in healthy human subjects: a dose-related study on systemic effects and peripheral CD4+ and CD8+ T cells. Respiratory Medicine 100: 519–528.
Kline, J.N., J.D. Cowden, G.W. Hunninghake, B.C. Schutte, J.L. Watt, C.L. Wohlford-Lenane, L.S. Powers, M.P. Jones, and D.A. Schwartz. 1999. Variable airway responsiveness to inhaled lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine 160: 297–303.
Michel, O., T.D. LeVan, D. Stern, M. Dentener, J. Thorn, D. Gnat, M.L. Beijer, P. Cochaux, P.G. Holt, F.D. Martinez, and R. Rylander. 2003. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. The Journal of Allergy and Clinical Immunology 112: 923–929.
Bland, J.M., and D.G. Altman. 1986. Statistical methods to assessing agreement beween two methods of clinical measurement. Lancet 1(8476): 307–310.
Pavord, I.D., M.M.M. Pizzichini, E. Pizzichini, and F.E. Hargraeve. 1997. The use of induced-sputum to investigate airway inflammation. Thorax 52: 498–501.
van der Vaart, H., D.S. Postma, W. Timens, H.F. Kauffman, M.N. Hylkema, and N.H. Ten Hacken. 2006. Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest 130: 1157–1164.
Schwartz, D.A., and D.N. Cook. 2005. Polymorphisms of the Toll-like receptors and human disease. Clinical Infectious Diseases 41(Suppl 7): S403–S407.
Martinez, F.D. 2007. CD14, endotoxin, and asthma risk: actions and interactions. Proceedings of the American Thoracic Society 4: 221–225.
ACKNOWLEDGMENTS
P. Dinh Huy Duc is supported by the CUD (Commission Universitaire au Développement).
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doyen, V., Kassengera, Z., Dinh, D.H.P. et al. Time Course of Endotoxin-Induced Airways’ Inflammation in Healthy Subjects. Inflammation 35, 33–38 (2012). https://doi.org/10.1007/s10753-010-9286-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-010-9286-0